Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2021 | 2022 | 2023 | |
|---|---|---|---|
| Revenue | $0 | $0 | $0 |
| Cost of revenue | $0 | $0 | $0 |
| Gross profit | $0 | −$1.8M | −$6.2M |
| Gross margin | — | — | — |
| R&D | $0 | $0 | $0 |
| Operating income | −$453.0K | −$1.8M | −$6.2M |
| EBITDA | $41.7K | −$10.2M | $10.1M |
| Net income | $9.5M | $9.9M | $3.9M |
| Net margin | — | — | — |
| EPS (diluted) | 0.33 | 0.34 | 0.14 |
Annual figures · source: Financial Modeling Prep
No one on the platform currently holds LCW.
No tracked institution reports a position in LCW as of their last filing.
No one on the platform has traded LCW yet.
| +0.83% |
| $161M |
| — |
| HCVIHennessy Capital Investment Corp. VI | $11.40 | +14.23% | $167M | — |
| NFYSEnphys Acquisition Corp. | $11.00 | +0.09% | $164M | — |
Source: Financial Modeling Prep · peers by sector/industry
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
Trading at 32.5× earnings vs its 30.3× historical median P/E.
Fair value ≈ $10.11 · price $10.87 today
Fair-value line = the stock's median historical P/E × earnings. Price below the orange line = cheap vs its own history; above = expensive. Not investment advice.